Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

@article{Arce2013AntimllerianHI,
  title={Antim{\"u}llerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.},
  author={J A Arce and Antonio La Marca and Bjarke Mirner Klein and Anders Nyboe Andersen and Richard Fleming},
  journal={Fertility and sterility},
  year={2013},
  volume={99 6},
  pages={1644-53}
}
OBJECTIVE To assess the relationships between serum antimüllerian hormone (AMH) and ovarian response and treatment outcomes in good-prognosis patients undergoing controlled ovarian stimulation using a gonadotropin-releasing hormone (GnRH) antagonist protocol. DESIGN Secondary analysis of data prospectively collected in a randomized, assessor-blind trial comparing two different gonadotropin preparations with respect to ongoing pregnancy rate. SETTING Twenty-five centers in seven countries… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS